Cerebral Hemorrhage Clinical Trial
Official title:
Prognostic Value of Plasma Thrombospondin-1 Levels After Acute Intracerebral Hemorrhageļ¼A Pilot Study
The current study was designed to investigate the change of plasma thrombospondin-1 levels and assess the prognostic predictive effect of plasma thrombospondin-1 levels in the patients with acute intracerebral hemorrhage.
Thrombospondin-1 acts as an anti-angiogenic factor and its expression in rat brain is upregulated after intracerebral hemorrhage. The current study was designed to investigate the change of plasma thrombospondin-1 levels and assess the prognostic predictive effect of plasma thrombospondin-1 levels in the patients with acute intracerebral hemorrhage. About 110 patients will be recruited. All blood samples from the patients at admission were collected. Thrombospondin-1 levels in plasma were measured using sandwich immunoassays. The patients will be followed up till 6 months after intracerebral hemorrhage. The relationships between plasma thrombospondin-1 levels and 1-week mortality, 6-month mortality, 6-month overall survival, 6-month unfavorable outcome (modified Rankin Scale score >2) and disease severity reflected by hematoma volume and National Institutes of Health Stroke Scale score were assessed using multivariate analysis. It is proposed that elevated plasma thrombospondin-1 levels are independently associated with disease severity and clinical outcomes. It will be suggested thrombospondin has potential to be a good prognostic biomarker of intracerebral hemorrhage. ;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04741334 -
Mild Head Injury, Antiplatelets, and Anticoagulants
|
||
| Completed |
NCT02565693 -
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
|
Phase 2 | |
| Recruiting |
NCT01866384 -
Targeted Temperature Management After Intracerebral Hemorrhage
|
Phase 2 | |
| Completed |
NCT00029315 -
Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
|
Phase 2 | |
| Active, not recruiting |
NCT06230419 -
Retrospective Study on the Direction of Artificial Intelligence in Identifying Cranial Trauma CT Imaging
|
||
| Not yet recruiting |
NCT04144868 -
Safety and Efficacy of NBO in Acute Intracerebral Hemorrhage
|
N/A | |
| Recruiting |
NCT05118997 -
Active Removal of IntraCerebral Hematoma Via Active Irrigation
|
N/A | |
| Active, not recruiting |
NCT02258919 -
Decompressive Hemicraniectomy in Intracerebral Hemorrhage
|
N/A | |
| Completed |
NCT01472224 -
Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound
|
N/A | |
| Recruiting |
NCT06078020 -
PLatform Study for INTracerebral Haemorrhage (PLINTH): Community-based Feasibility Study
|
||
| Completed |
NCT01467206 -
Life After STroke - the LAST Study
|
N/A | |
| Completed |
NCT00226096 -
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
|
N/A | |
| Recruiting |
NCT03815149 -
Safety and Clinical Effectiveness of Pipelineā¢ Shield Devices for Intracranial Aneurysms
|
||
| Completed |
NCT00579943 -
Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants
|
N/A | |
| Recruiting |
NCT05424614 -
Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence
|
||
| Completed |
NCT03000283 -
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study
|
Phase 1 | |
| Active, not recruiting |
NCT02283879 -
Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela
|
Phase 1 | |
| Active, not recruiting |
NCT02240394 -
TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure
|
N/A | |
| Completed |
NCT01858675 -
Biomarkers Correlation With Volemia
|
N/A | |
| Completed |
NCT00363662 -
Diagnostic Utility of MRI in Intracerebral Hemorrhage
|